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Device implantations may be challenging in patients with
venous abnormalities. The most common congenital variation,
frequently associated with other congenital abnormalities, is a
persistent left superior vena cava (PLSVC), and successful atrial
and ventricular lead implantation via a PLSVC have both been
reported [1].
“Ratchet syndrome” has also been reported as a rare compli-
cation after a newly implanted pacemaker or implantable
cardioverter-deﬁbrillator (ICD) and involves lead dislodgement
and retraction due to a ratchet-like movement through the suture
sleeve that causes a continuous short pull [2,3]. Here, we present a
rare case in which successful dual-chamber ICD implantation via a
PLSVC was achieved after the occurrence of ratchet syndrome.2. Case
A 63-year-old woman with arrhythmogenic right ventricular
cardiomyopathy (ARVC) experienced a sustained monomorphic
ventricular tachyarrhythmia (VT) unresponsive to drug therapy.
She underwent implantation of a dual chamber ICD (TELIGEN 100
F111, Boston Scientiﬁc Inc., St. Paul, MN, USA) using active ﬁxation
leads for both the atrial (DEXTRUS 4136, Boston Scientiﬁc Inc.) and
ICD leads (ENDOTAK RELIANCE G, Boston Scientiﬁc Inc.) for the
secondary prevention of VT. Venography conﬁrmed a PLSVC andx.doi.org/10.1016/j.joa.2016.01.003
76/& 2016 Japanese Heart Rhythm Society. Published by Elsevier B.V. This is an
reativecommons.org/licenses/by-nc-nd/4.0/).
esponding author. Tel.: þ81 489 65 1111; fax: þ81 489 60 1708.
ail address: nshiro@dokkyomed.ac.jp (S. Nakahara).revealed no small branch that would allow the PLSVC to com-
municate with the right-sided venous drainage (Fig. 2A). Thus, ICD
implantation was performed from the right subclavian vein
because of the PLSVC. The suture sleeves were secured with two
non-absorbable monoﬁlament sutures for each. The active ﬁxation
lead was placed into the right atrial appendage (stimulation
threshold measured as 1.4 V at 0.4 ms, and atrial wave amplitude
2.1 mV), and the ICD lead was placed into the right ventricular
apex (stimulation threshold measured as 1.0 V at 0.4 ms, and R-
wave amplitude 7.1 mV). The lead position after the operation was
identical. After 2 months, an atrial lead dislodgement was docu-
mented (Fig. 1A). Eventually the lead retracted fully and sponta-
neously into the ICD pocket (Fig. 1B). The electro-cardiogram
revealed right ventricular pacing without atrial pacing (Fig. 2B).
After the loss of atrial pacing, chest radiography revealed cardio-
megaly. We considered that progressive heart failure had occurred
due to the high frequency of ventricular pacing (Fig. 1B).
Six months after the ﬁrst implantation, a reimplantation pro-
cedure was performed. The atrial lead was easily removed from
the pocket, and a new lead placement was attempted. Using a
venogram as a guide, the axillary vein was found to be almost
totally occluded (Fig. 2C) with collateral development, and the
guidewire could not pass through the axillary vein after the
puncture. The patient had right-arm edema 2 months before
admission, so this venous trouble was strongly suspected to have
coincided with the emergence of edema. The previous ICD lead
was smoothly extracted without forcibly tugging, with a back-up
cardiac surgical team. After extraction of the previous lead, we
attempted to implant both the atrial and ICD leads from the left
pectoral region via the PLSVC (Fig. 2D). The atrial lead wasopen access article under the CC BY-NC-ND license
Fig. 1. (A) A chest radiograph taken 2 months after the operation. The tip of the atrial lead is located at the mid portion of the superior vena cava (indicated by the arrow).
(B) Full retraction of the atrial lead into the pocket (arrow) at the time of subacute exacerbation of her heart failure. (C) The alpha conﬁguration of the implantable
cardioverter deﬁbrillator lead and atrial lead implanted via the persistent left superior vena cava (PLSVC). (D) Dramatic improvement in heart failure after the successful dual
lead implantation, with complete atrial pacing and without any ventricular pacing.
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lead, access to the right ventricle was achieved using a hand-
shaped stylet, ﬁrst advancing the lead towards the lateral wall of
the right atrium and subsequently with the tip of the lead pointing
towards the atrium into the right ventricle. Eventually, the ICD
lead was placed with a loop on the lead across the tricuspid valve
(Fig. 1C). After successful implantation, the patient's heart failure
dramatically improved with complete atrial pacing and without
any ventricular pacing (Fig. 1D).3. Discussion
Lead dislodgement with loss of the pacing and sensing function
is a serious complication after the implantation of cardiac
implantable devices [4–6]. “Ratchet syndrome” is recognized as a
rare complication involving lead dislodgement and retraction that
occurs by a ratchet-like mechanism. A previous paper has sug-
gested that the underlying ratchet-like mechanism is a con-
sequence of repetitive upward and downward movements of the
shoulder and/or arm along with weak tightening of the ﬁxation-
sleeve suture. Although the right hand was dominant in this
patient, we had implanted the device system in a right pectoral
site due to the existence of the PLSVC. Furthermore, the oval-
shaped device used in this case had square and ﬂat edges, and this
may have allowed surplus space for the suture and lead to move
within the device pocket. Therefore, it is quite possible that acontinuous “pushing and pulling” of the lead may have constituted
the proposed ratchet-like mechanism in this case [6]. In addition,
only the atrial lead was dislodged, and it was suspected that
loosening of the suture on only the atrial lead ﬁxation sleeve had
occurred during the ﬁrst implant procedure.
This patient had sick-sinus syndrome and also took sotalol for
the prevention of VT related to ARVC. Therefore, constant atrial
pacing was indispensable for maintaining a physiological atrial
rhythm. Frequent right ventricular pacing is known to cause left
ventricular dysfunction, myocardial perfusion defects, abnormal
septal contractility, and heart failure in some patients [7,8].
Therefore, it appears possible that the dominant ventricular pacing
that occurred after the dislodgement of the atrial lead caused
exacerbation of her chronic heart failure.
ICD lead implantation through a PLSVC is often challenging and
sometimes unsuccessful [9]. A loop on the lead across the tricuspid
valve can result in higher mechanical stress, making it prone to
lead failure [10,11]. Furthermore, this patient may need an
upgrade from an ICD to a cardiac resynchronization therapy device
in the near future because of the presence of cardiomyopathy, but
a left ventricular (LV) lead implantation via a PLSVC seems difﬁ-
cult. A recent paper has demonstrated both successful ICD [12] and
LV [13,14] lead implantation through a small branch commu-
nicating between a PLSVC and the right-sided venous drainage.
However, as in our case, the PLSVC and right superior vena cava
are not connected by a communicating branch in 40% of cases
(Fig. 2A) [15]. Thus, before the implantation procedure, the PLSVC
Fig. 2. (A) Venogram from the left subclavian vein showing the persistent left superior vena cava without a communicating branch. AP, anteroposterior. (B) Twelve-lead
electrocardiogram during complete ventricular pacing, which appeared after the dislodgment of the atrial lead. (C) Venogram showing partial occlusion of the axillary vein
(white arrow) with the development of collaterals (white dotted arrow). (D) Venogram showing the persistent left superior vena cava and the coronary sinus (CS). LAO, left
anterior oblique.
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branches or appropriate lateral coronary veins using detailed
venography.
The current generation of ICDs is also capable of achieving
acceptable deﬁbrillation thresholds when placed in the right
pectoral region [16]. However, the easier method of performing a
right-sided ICD implantation in patients with both a PLSVC and
dextral dominance may cause an unusual form of lead dislodge-
ment. To prevent an iatrogenic complication after an unavoidable
right-sided implantation, such as that reported here, tightening of
the suture on the lead ﬁxation sleeve should be recommended.Conﬂict of interest
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